Loading insider details...
Beta
Latest Form 4 (Aug 27, 2026): Disposition to Issuer of 2,000 FBRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Forte Biosciences, Inc. (FBRX) | Disposition to Issuer | 2,000 | n/a |
| Jun 2, 2026 | Forte Biosciences, Inc. (FBRX) | Grant/Award | 18,353 | n/a |
| Mar 21, 2025 | Forte Biosciences, Inc. (FBRX) | Grant/Award | 31,000 | n/a |
| Sep 19, 2024 | Forte Biosciences, Inc. (FBRX) | Grant/Award | 2,000 | n/a |
| Feb 15, 2024 | Oncternal Therapeutics, Inc. (ONCT) | Grant/Award | 14,200 | n/a |
| Jan 5, 2024 | Oncternal Therapeutics, Inc. (ONCT) | Tax Withholding | 8,868 | $4.4K |